Growth Metrics

Vertex Pharmaceuticals (VRTX) Share-based Compensation Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -34.72%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 4.80%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 10.78%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 20.65%
10 Revolution Medicines 31.20 Bn 31.20 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.78%
Dec 31, 2025 12.23%
Sep 30, 2025 12.85%
Jun 30, 2025 13.67%
Mar 31, 2025 8.43%
Dec 31, 2024 12.26%
Sep 30, 2024 21.47%
Jun 30, 2024 13.81%
Mar 31, 2024 18.54%
Dec 31, 2023 29.05%
Sep 30, 2023 9.56%
Jun 30, 2023 0.60%
Mar 31, 2023 1.89%
Dec 31, 2022 6.77%
Sep 30, 2022 16.65%
Jun 30, 2022 8.29%
Mar 31, 2022 11.58%
Dec 31, 2021 14.53%
Sep 30, 2021 6.39%
Jun 30, 2021 8.26%
Mar 31, 2021 13.82%
Dec 31, 2020 8.38%
Sep 30, 2020 10.16%
Jun 30, 2020 17.04%
Mar 31, 2020 18.55%
Dec 31, 2019 13.89%
Sep 30, 2019 11.75%
Jun 30, 2019 13.13%
Mar 31, 2019 19.13%
Dec 31, 2018 20.92%
Sep 30, 2018 9.17%
Jun 30, 2018 9.23%
Mar 31, 2018 10.84%
Dec 31, 2017 21.62%
Sep 30, 2017 70.56%
Jun 30, 2017 19.86%
Mar 31, 2017 14.24%
Dec 31, 2016 38.43%
Sep 30, 2016 47.29%
Jun 30, 2016 14.42%
Mar 31, 2016 21.05%
Dec 31, 2015 17.34%
Sep 30, 2015 33.57%
Jun 30, 2015 26.33%
Mar 31, 2015 27.50%
Dec 31, 2014 13.41%
Sep 30, 2014 -20.10%
Mar 31, 2014 18.66%
Dec 31, 2013 -0.29%
Sep 30, 2013 -6.94%
Jun 30, 2013 19.14%
Mar 31, 2013 17.39%
Dec 31, 2012 15.95%
Sep 30, 2012 11.06%
Jun 30, 2012 5.68%
Mar 31, 2012 7.52%